We have demonstrated previously [23,24] that the PPARγ agonist, rosiglitazone enhances UCP2 expression in the hippocampal neurons, leading to protection against oxidative stress and neuronal cell death associated with cerebral ischemia. The gene discussed is UCP2; the disease is brain ischemia.